Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Urology

Search Medical Condition
Please enter condition
Please choose location

Urologic Cancer Clinical Trials

A listing of Urologic Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (112) clinical trials

Study evaluating the safety and efficacy of TAK-385, an oral Gonadotropin-Releasing Hormone Antagonist, for patients with localized Prostate Cancer requiring NeoAdjuvant and Adjuvant Androgen Deprivation Therapy with External Beam Radiation Therapy. This study will evaluate the efficacy of TAK-385 for achieving and maintaining testosterone suppression and evaluate the safety and ...

Phase

This study evaluates the efficacy of TAK-385 for achieving and maintaining testosterone suppression. Evaluates the safety and tolerability of TAK-385, evaluates the efficacy for prostate specific antigen (PSA) lowering. This study also evaluates the quality of life related to androgen deprivation and recovery from androgen deprivation therapy using validated patient-reported ...

Phase

Patients with newly diagnosed or recurrent high risk non-muscle invasive bladder cancer who have undergone transurethral resection of bladder tumor (TURBT) and received 3-6 instillations of intravesical treatment with BCG induction therapy will be enrolled in this two stage study.

Phase N/A

Phase II, open lable study of effect of GTx-758 as secondary hormonal therapy on serum PSA and serum free testosterone levels in men with metastatic castration resistant prostate cancer maintained on androgen deprivation therapy. This study assess the effect of GTx-758 on serum free testosterone levels and serum SHBG.

Phase

The purpose of this study is to demonstrate superiority in the metastasis-free survival of men with high risk non-metastatic castration-resistant prostate cancer treated with ARN-509 versus placebo. The study will compare the time to symptomatic progression and compare time to metastasis while treated with ARN-509 versus the placebo. Evaluations will ...

Phase

The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.

Phase N/A

The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

Phase

A Multi-Center, Open Label, Phase 2b study, Evaluating the safety, tolerability and efficacy of Targeted Intraprostatic Administration of XXXXX to treat men with histologically proven, clinically significant, localized, Low-to Intermediate-Risk Prostate Cancer that is associated with an MRI Leasion

Phase

The purpose of this research study is to evaluate the effectiveness and safety of one dose of rAd-IFN with Syn3 (InstiladrinTM) given to patients with High Grade BCG-unresponsive non-muscle invasive bladder cancer. Instiladrin™ is a gene transfer agent and is being developed for transfer of the Interferon a-2b gene in ...

Phase N/A

The main purpose of this study is to see if Niraparib is useful to treat men with advanced prostate cancer. The safety of niraparib will also be studied.

Phase N/A